News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Sabine D. Brookman-May: Updated analysis with additional FU of EV 302 in 1st line advanced Bladder Cancer
Sabine D. Brookman-May/X
Feb 18, 2025, 19:32

Sabine D. Brookman-May: Updated analysis with additional FU of EV 302 in 1st line advanced Bladder Cancer

Sabine D. Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences, shared a post on X:

“Updated analysis with additional FU of EV 302 EV+P in 1st line advanced Bladder Cancer.

  • PFS & OS benefit in all groups.
  • Benefit in cisplatin eligible/ineligible.
  • Safety consistent with prior analysis.
  • mDOR close to 2 years.

 Sabine D. Brookman-May: Updated analysis with additional FU of EV 302 in 1st line advanced Bladder Cancer

Aura Biosciences bladder cancer cancer Cisplatin fight against cancer Global fight against cancer OncoDaily Oncology Sabine D. Brookman-May urologic oncology
Special Coverage
Blog
Mar 13, 2025, 11:07
Yan Leyfman: Phenomenal Grand Rounds by Global Cell Therapy Leader - Katy Rezvani
Blog
Mar 13, 2025, 10:43
Eric Bouffet about My Child Matters project - Foundation S
Blog
Mar 13, 2025, 10:14
Miriam Mutebi: Breast cancer is a growing crisis in Africa
Blog
Mar 13, 2025, 10:06
The Call for Abstract for IUCS25 is open - International Urology Cancer Summit
Science
Mar 13, 2025, 09:32
Myeloma Paper of the Day, March 13th, suggested by Robert Orlowski
Science
Mar 13, 2025, 09:10
George Vlachogiannis: Radical surgery vs RTH for sacral chordoma treatment
Blog
Mar 13, 2025, 09:07
Translating Genomic Discoveries into Therapies with Triparna Sen - GRACE
Blog
Mar 13, 2025, 08:55
The Improving Care of EBC Patients in Europe Investigators Meeting - SPCC
Blog
Mar 13, 2025, 08:44
RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression 
Science
Mar 13, 2025, 08:43
Wafik S. El-Deiry: Worldwide Innovative Network Consortium in Personalized Cancer Medicine
Blog
Mar 13, 2025, 08:31
Tanja Obradovic: Turmoil within the Biotech sector continues as financing remains a challenge
Blog
Mar 13, 2025, 08:21
Pawel Sobczuk: The first ever scientific conference dedicated to young "oncologists" in Poland